Imke Satzger

Summary

Affiliation: Hannover Medical School
Country: Germany

Publications

  1. ncbi [Intravascular lymphoma: two case reports demonstrating the heterogeneity of the disease]
    I Satzger
    Klinik und Poliklinik fur Dermatologie und Venerologie, Medizinische Hochschule Hannover, Hauttumorzentrum Hannover HTZH, Ricklinger Strasse 5, Hannover, Germany
    Hautarzt 60:131-6. 2009
  2. ncbi Sentinel node dissection delays recurrence and prolongs melanoma-related survival: an analysis of 673 patients from a single center with long-term follow-up
    I Satzger
    Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany
    Ann Surg Oncol 18:514-20. 2011
  3. ncbi Therapeutic use of erythropoietin in dermatooncology
    Imke Satzger
    Department of Dermatology and Venereology, Skin Tumor Center, Hannover Medical School, Hannover, Germany
    J Dtsch Dermatol Ges 5:280-5. 2007
  4. ncbi Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodes
    Imke Satzger
    Department of Dermatology, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany
    Am J Surg Pathol 31:1175-80. 2007
  5. ncbi MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma
    Imke Satzger
    Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany
    Int J Cancer 126:2553-62. 2010
  6. ncbi Criteria in sentinel lymph nodes of melanoma patients that predict involvement of nonsentinel lymph nodes
    Imke Satzger
    Department of Dermatology and Allergology, Skin Cancer Center Hannover, Hannover Medical School, Ricklinger Str 5, 30449 Hannover, Germany
    Ann Surg Oncol 15:1723-32. 2008
  7. ncbi Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas
    I Satzger
    Department of Dermatology and Allergology, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany
    Br J Cancer 99:2065-9. 2008
  8. ncbi Comparison of classification systems in melanoma sentinel lymph nodes--an analysis of 697 patients from a single center
    Andre Meier
    Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany
    Cancer 116:3178-88. 2010
  9. ncbi Anal mucosal melanoma with KIT-activating mutation and response to imatinib therapy--case report and review of the literature
    Imke Satzger
    Skin Cancer Center Hannover, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany satzger imke mh hannover de
    Dermatology 220:77-81. 2010
  10. ncbi Age as a key factor influencing metastasizing patterns and disease-specific survival after sentinel lymph node biopsy for cutaneous melanoma
    Lutz Kretschmer
    Department of Dermatology, Venereology and Allergology, Georg August University of Goettingen, Gottingen, Germany
    Int J Cancer 129:1435-42. 2011

Collaborators

Detail Information

Publications16

  1. ncbi [Intravascular lymphoma: two case reports demonstrating the heterogeneity of the disease]
    I Satzger
    Klinik und Poliklinik fur Dermatologie und Venerologie, Medizinische Hochschule Hannover, Hauttumorzentrum Hannover HTZH, Ricklinger Strasse 5, Hannover, Germany
    Hautarzt 60:131-6. 2009
    ..The other patient had distinctive cutaneous and neurological symptoms which did not respond to therapy. By means of these two patients, we present the heterogeneity of IVL and discuss current aspects of diagnosis and treatment...
  2. ncbi Sentinel node dissection delays recurrence and prolongs melanoma-related survival: an analysis of 673 patients from a single center with long-term follow-up
    I Satzger
    Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany
    Ann Surg Oncol 18:514-20. 2011
    ..A large series of melanoma patients from a single center with long-term follow-up was analyzed with regard to a possible effect of SLND on the prognosis...
  3. ncbi Therapeutic use of erythropoietin in dermatooncology
    Imke Satzger
    Department of Dermatology and Venereology, Skin Tumor Center, Hannover Medical School, Hannover, Germany
    J Dtsch Dermatol Ges 5:280-5. 2007
    ..We review here current guidelines on the use of erythropoietin in cancer patients and report on our own melanoma patients treated with erythropoietin for chemotherapy-induced anemia...
  4. ncbi Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodes
    Imke Satzger
    Department of Dermatology, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany
    Am J Surg Pathol 31:1175-80. 2007
    ..In conclusion, with short-term follow-up IPC in melanoma SLN are without prognostic significance...
  5. ncbi MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma
    Imke Satzger
    Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany
    Int J Cancer 126:2553-62. 2010
    ..MiR-15b appears to represent a particular important miRNA in melanoma that is associated with poor prognosis and tumorigenesis...
  6. ncbi Criteria in sentinel lymph nodes of melanoma patients that predict involvement of nonsentinel lymph nodes
    Imke Satzger
    Department of Dermatology and Allergology, Skin Cancer Center Hannover, Hannover Medical School, Ricklinger Str 5, 30449 Hannover, Germany
    Ann Surg Oncol 15:1723-32. 2008
    ..Such criteria may facilitate the selection of patients who might benefit from a completion lymph node dissection (CLND). However, it is currently unclear which parameters are most important...
  7. ncbi Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas
    I Satzger
    Department of Dermatology and Allergology, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany
    Br J Cancer 99:2065-9. 2008
    ..Our data encourage therapeutic attempts with tyrosine kinase inhibitors blocking c-KIT in these patients...
  8. ncbi Comparison of classification systems in melanoma sentinel lymph nodes--an analysis of 697 patients from a single center
    Andre Meier
    Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany
    Cancer 116:3178-88. 2010
    ..The authors of this report compared the RFS and OS of 697 melanoma patients as predicted by various classification systems...
  9. ncbi Anal mucosal melanoma with KIT-activating mutation and response to imatinib therapy--case report and review of the literature
    Imke Satzger
    Skin Cancer Center Hannover, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany satzger imke mh hannover de
    Dermatology 220:77-81. 2010
    ..We report here on one of our patients with KIT-activating mutation in metastatic anal mucosal melanoma, who showed a response to imatinib therapy and summarize the available literature regarding this new therapeutic option...
  10. ncbi Age as a key factor influencing metastasizing patterns and disease-specific survival after sentinel lymph node biopsy for cutaneous melanoma
    Lutz Kretschmer
    Department of Dermatology, Venereology and Allergology, Georg August University of Goettingen, Gottingen, Germany
    Int J Cancer 129:1435-42. 2011
    ..Younger patients have a better prognosis despite their higher probability of SLN metastasis. Older patients are less frequently SLN-positive but have a higher risk of loco-regional recurrence...
  11. ncbi Sentinel lymph node status is the most important prognostic factor for thick (> or = 4 mm) melanomas
    Ralf Gutzmer
    Department of Dermatology and Venereology, Skin Tumor Center Hannover HTZH, Hannover Medical School, Hannover, Germany
    J Dtsch Dermatol Ges 6:198-203. 2008
    ..The value of the status of the sentinel lymph node (SLN) in patients with thick melanomas (Breslow thickness > or = 4 mm) is controversial...
  12. ncbi Autoimmunity as a prognostic factor in melanoma patients treated with adjuvant low-dose interferon alpha
    Imke Satzger
    Department of Dermatology and Allergology, Hannover Medical School, Hautklinik Linden, Klinikum Region Hannover, Skin Cancer Center Hannover, Hannover, Germany
    Int J Cancer 121:2562-6. 2007
    ..Thus, autoimmunity triggered by low-dose IFN therapy appears to indicate an improved prognosis and should encourage continuation of IFN therapy...
  13. ncbi The hand-foot-syndrome associated with medical tumor therapy - classification and management
    Annette Degen
    Clinic and Polyclinic for Dermatology, and Allergy, Skin Cancer Center Hannover HTZH, Hannover Medical School, Germany
    J Dtsch Dermatol Ges 8:652-61. 2010
    ..In this review, similarities and differences between chemotherapy- and MKI-associated HFS are discussed and current recommendations for their prophylaxis and management are summarized...
  14. ncbi Tumoral melanosis involving the sentinel lymph nodes: a case report
    Imke Satzger
    Department of Dermatology and Allergology, Hannover Medical University, Hannover, Germany
    J Cutan Pathol 34:284-6. 2007
    ..We present a patient with nodular melanosis involving also the sentinel lymph nodes and discuss possible differential diagnoses as well as prognostic and therapeutic implications...
  15. ncbi Atypical cutaneous herpes virus infection associated with fludarabine chemotherapy of lymphoma
    Imke Satzger
    Eur J Dermatol 17:165-6. 2007
  16. ncbi Spontaneous regression of melanoma with distant metastases - report of a patient with brain metastases
    Imke Satzger
    Eur J Dermatol 16:454-5. 2006